Edwards buys mitral valve technology from ev3
This article was originally published in Clinica
Executive Summary
Edwards Lifesciences has expanded its expertise in less invasive mitral valve repair with the $15m acquisition of technology from ev3.
You may also be interested in...
Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
Medtech Industry Favorite Wins Seat On Powerful House E&C Committee
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
Source: 3 Former Obama US CMS Officials Being Considered To Lead Biden’s Medicare Agency
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: